Health
Moderna Sinks on AstraZeneca Covid-19 Vaccine Progress, JPMorgan Downgrade – Investing.com
Moderna Sinks on AstraZeneca Covid-19 Vaccine Progress, JPMorgan Downgrade
By Christiana Sciaudone
Investing.com — Moderna (NASDAQ:MRNA) dropped 14% after AstraZeneca (NYSE:AZN) and Oxford University said their vaccine candidate showed promise.
The AstraZeneca-Oxford vaccine, AZD1222, is safe and produced an immune response in early-stage clinical trials in healthy volunteers, Reuters reported, citing data from The Lancet. No serious side effects were reported.
JPMorgan (NYSE:JPM) downgraded Moderna, which is working on a separate vaccine candidate, today on a hig…
-
General21 hours agoVote counting begins for Townsville mayoral by-election
-
General24 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
Noosa News23 hours agoLGAQ motions become voice for community
-
Business13 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI